Therefore, we measured the expression of EMT markers, including E-cadherin, N-cadherin, vimentin, and matrix metalloproteinase-9 (MMP9) in CRC cells with CSPG4P12 overexpression. This evidence concerns the gene CDH2 and colorectal carcinoma.